Bitter Pills:Medicines & The Third World Poor | Page 64

Would you rather have your doctor choose a medicine for you-or somebody else ? Somebody other than a doctor may choose a medicine for you if brand names for drugs are abolished and doctors are compelled to prescribe by generic name only A generic name is the common name of a drug — usually a long chemical name. When this drug is made by several firms, each one gives il an easy-to-remember brand name, which is usually simpler than the generic name Simplicity or Confusion ? "Bromodiphenhydramine Hydrochloride" is a generic name. It is marketed by companies under (heir own brand names. "Ambrodryl", for example, is a brand name for this drug. Similarly, "Dihydro-ergotamine Methanesulphonate" is the generic name of a drug marketed as "Dihydergot", a brand rvame. "Otrivin" is a brand name of a drug generically named "Xylometazoline Hydrochlonde" Brand names usually have no similarity in spelling or pronunciation. Hence the chances of wrong dispensing of a drug prescribed by a brand name are negligible. In contrast, several generic names are similar in spelling and pronunciation, although the drugs concerned may be quite different in their therapeutic action Example Quinidme Sulphate is a cardiac *drug. while similar-sounding Quinine Sulphate is an anti-malarial If doctors are forced to prescribe drugs by generic names, the chances of wrong dispensing by chemists can be very high, especially if prescriptions are illegibly written as they often are Layman's View Laymen think that all products with the same chemical composition have the same degree of Do you have these misconceptions ? The move to abolish brand name is motivated by the erroneous belief that if there are no brands, drugs will become cheap er. This belief may have some limited validity in countries which permit free competition. But in India the price of every drug is rigidly controlled by the Government. The Government also lays down which company should produce what drug and in what quantity. The profits that drug companies can make are also controlled. As price control applies squally to generic* and brands, there is no question of drugs becoming cheaper if brand names are abolished. Another misconception is that the brand system somehow favours large firms against small manufacturers. All quality-conscious drug manufacturers - both large as well as small - are in favour of the brand system which wins them consumers on the basis of merit. effectiveness. But chemical equivalence is not the same as therapeutic equivalence, as every good doctor knows. This is because drug quality and effectiveness are not simply a matter of how a medicine is named or marketed, but how and by whom it is made Several critical factors, which differ from company to company.'vitally affect the effectiveness of a drug in patients. These differences can. and often do, result in variations in the degree and speed of therapeutic response -how much of the drug is absorbed, where in the body and how rapidly it is assimilated, allergic reactions or other side-effects, tolerance by the patient in specific conditions, etc. Doctor Knows Best Thts being so, the doctor, who knows the patient's condition better than anybody else and has previously observed the action of different brands of the medicine, chooses a brand he knows to be effective and is best for the patiem. If brand names are abolished, the doctor will have to prescribe by generic name. When you take the prescnptron to the drug store, the chemist will decide which com- 57 pany's product should be given to the patient. And the chemist, unlike the doctor, has no knowledge of the patient's condition, nor has he any experience of the therapeutic effects of products made by different companies. Ensuring Quality When a company markets a product under a brand name, it slakes its reputation on the brand This is a less, expensive way of ensuring quality than administrative controls The Soviet Union has retained the brand system. When Pakistan abolished brands, spurious and substandard drugs took over The country has gone back to brands It is obvious that the abolition of brand names will jeopardise the interests of ihe consumer without any corresponding benefit like lower prices There is no justification for taking this risk in such a vital field as medical care